Searching Content indexed under Litigation, Mediation & Arbitration by Shon Lo ordered by Published Date Descending.
Links to Result pages
Counting The Days: PTA Calculated From Date National Stage Commences
Addressing the patent term adjustment (PTA) calculations under 35 USC § 154(b)(1)(A)(i)(II), the US Court of Appeals for the Federal Circuit held that an applicant must comply with the "express request" ...
United States
5 Apr 2018
Unpredictable Biology, Non-Analogous Art Go Against Reasonable Expectation of Success
Plerixafor disrupts this bond, releasing the stem cell from the bone marrow into the bloodstream, so that the stem cells can then be collected from a patient's blood.
United States
19 Mar 2018
NJ Court Grants Exceptional Case Fees Based On Speculative Infringement Suit
The court then determined how much time was reasonably expended on the matter.
United States
5 Dec 2017
Court Dismisses Infringement Theory Premised On Speculated Future Formulation Changes
The US District Court for the District of New Jersey granted generic manufacturer's motion for judgment on the pleadings under Fed. R. Civ. P. 12(c) on the basis of non-infringement.
United States
23 Aug 2017
Export Of Single Component Of Patented Combination Does Not Impose Liability Under § 271(f)(1)
In reversing the US Court of Appeals for the Federal Circuit, an essentially unanimous Supreme Court of the United States ruled that the "supply of a single component of a multi-component invention for manufacture abroad does not give rise to liability" under 35 USC § 271(f)(1).
United States
19 Apr 2017
Inherent Disclosure Supplies Adequate Written Description For Priority Claim
Abbott is the owner of a patent that discloses and claims a protein called TBP-II with a particular 15 amino acid sequence at its N-terminus.
United States
1 Nov 2016
Foreign Proceedings Do Not Trigger § 315(b) Time Bar
The petitioner, Micron, requested IPR of an MIT patent relating to using a laser in cutting parts of a circuit.
United States
4 Jan 2016
District Court Upholds Exclusivity Rights On Antibiotic Astragraf XL
Veloxis elected not to accept the FDA's proposed compromise, and sought judicial review of the FDA's decision that it would not approve Envarsus XR until Astagraf XL's exclusivity expired.
United States
3 Nov 2015
Federal Court Affirms Invalidity Of Sterile Budesonide Claims
The U.S. Court of Appeals for the Federal Circuit recently affirmed the obviousness of claims directed to sterile, pharmaceutically effective budesonide compositions.
United States
30 Jul 2015
Statute Intended To Close Deepsouth Loophole Given Broad Interpretation
The asserted patents relate to DNA amplification kits. Specifically, the kits amplify "short tandem repeats" (STR) found in the human genome at locations called STR loci.
United States
3 Feb 2015
Links to Result pages